Back to Search
LILLIAN KHOR, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1851403836Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
4979082-1205(UT)
Research & Publications (17)
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease.
PMID 15501203·Am J Med·2004
4-observational
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
PMID 19464826·Int J Radiat Oncol Biol Phys·2009
8-other
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
PMID 18455330·Int J Radiat Oncol Biol Phys·2008
3-trial
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
PMID 17881290·Lancet Oncol·2007
3-trial
Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.
PMID 17703179·Genes Immun·2007
8-other
Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.
PMID 17637390·Int J Radiat Oncol Biol Phys·2007
7-preclinical
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
PMID 17634487·J Clin Oncol·2007
3-trial
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
PMID 17575222·Clin Cancer Res·2007
3-trial
Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.
PMID 17382154·Urology·2007
3-trial
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
PMID 16814949·Int J Radiat Oncol Biol Phys·2006
8-other
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610.
PMID 16007688·Cancer·2005
8-other
Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.
PMID 15993550·Int J Radiat Oncol Biol Phys·2005
8-other
[In vitro chemosensitivity test for hepatocellular carcinoma using collagen-gel droplet embedded cultures].
PMID 15628760·Gan To Kagaku Ryoho·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 N 1900 E, ROOM 4A100
SALT LAKE CITY, UT 84132 - Phone
- (801) 585-2341
Quick Facts
- NPI
- 1851403836
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile